Please register to participate in our discussions with 2 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
Second ranitidine class action decision reaffirms that claims are without merit
On May 11, 2023, the British Columbia Supreme Court handed down a decision entirely dismissing a proposed class action lawsuit on behalf of Canadians who had purchased or taken ranitidine. The decision to dismiss this claim reinforces a previous decision made by the Ontario Superior Court on the same topic.
Pharmascience, as a drug manufacturer, is pleased to see this decision as we believe the two recent cases were without merit.
California had some settlements but the $$ amount was not disclosed. In the US I guess it's cheaper to just give someone some cash rather than fight in court for years.
Quote:
GSK on Wednesday said it agreed to settle another lawsuit in California alleging its discontinued heartburn drug Zantac caused cancer, as the British drugmaker sought to end costly litigation that has weighed on shares.
The company, which has so far only settled cases in California, did not give the financial details of the settlement but said it was a "non-material" sum.
Please register to participate in our discussions with 2 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
